RECRUITING

The Impact of Chronic E-Cigarette Usage on Microvascular Health

Talk to us

Conditions

E-Cig UseMicrovascular Health

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study is focused on investigating the mechanisms involved in microvascular health in subjects that use e-cigarettes frequently. To explore microvascular health, different techniques and compounds. For one of the tests, iontophoresis, the drug's use will be stored and handled as described by the approved IND and non-IDS plan.

Official Title

The Impact of Chronic E-Cigarette Usage on Microvascular Health

Quick Facts

Study Start:2023-07-14
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06860698

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 29 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Between 18 and 29 years of age
  2. * Used e-cigarettes with nicotine (≥3 times/week for ≥6 months)
  1. * 17 years old and younger or 30 years old or older.
  2. * Former combustible tobacco user/ former smoker
  3. * Use of cigarettes for 15 days or more in the past 60 days
  4. * Use of other tobacco products (cigars, hookah, smokeless), marijuana and/or illicit or prescription drugs weekly or more frequently in the past 60 days
  5. * Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, cerebral diseases or sleep disorders
  6. * Disorder or use of medication that affects cardiopulmonary health
  7. * Evidence of pregnancy or current nursing
  8. * 17 years old and younger or 30 years old and older
  9. * Use of cigarettes or other tobacco products more than 50 times in their lifetime.
  10. * Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, cerebral diseases or sleep disorders
  11. * Disorder or use of medication that affects cardiopulmonary health
  12. * Evidence of pregnancy or current nursing

Contacts and Locations

Study Contact

Paula Rodriguez Miguelez
CONTACT
(804) 396-4498
prodriguezmig@vcu.edu

Principal Investigator

Paula Rodriguez Miguelez
PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University

Study Locations (Sites)

Virginia Commonwealth University
Richmond, Virginia, 23298
United States

Collaborators and Investigators

Sponsor: Virginia Commonwealth University

  • Paula Rodriguez Miguelez, PRINCIPAL_INVESTIGATOR, Virginia Commonwealth University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-14
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2023-07-14
Study Completion Date2025-09-30

Terms related to this study

Keywords Provided by Researchers

  • Microvascular Health

Additional Relevant MeSH Terms

  • E-Cig Use